Authors


Jai G. Parekh, MD, MBA, FAAO

Latest:

Paying attention to ocular surface disease preoperatively matters

Look for fluctuating vision, test objectively and keep a few effective tools at your disposal to treat OSD.


By Hattie Hayes; Reviewed by Anat Loewenstein, MD

Latest:

The “fourth dimension” of home monitoring

A longitudinal, AI-based approach to fluid quantification


Dr Vanita Berry, Prof. Roy A. Quinlan and Prof. Michel Michaelides

Latest:

Understanding the molecular mechanisms underlying cataract development

A greater understanding of lens embryology and the phenotype/genotype correlation of cataracts should help guide future therapeutic approaches.


Dr Brett Mueller

Latest:

For younger patients with mid-range myopia, consider phakic IOLs

The implantable lenses can offer an advantage over laser surgery


Prof. Navid Ardjomand

Latest:

How to use topography-guided laser procedures to treat keratoconus

Topography-guided PRK, with or without the addition of corneal crosslinking, can improve visual acuity and quality in patients with keratoconus.


Dr Victor A. Augustin
Dr Victor A. Augustin

Latest:

Artificial DMEK could help tackle endothelial donor tissue shortage

Newly developed acrylic implant provides option for patients with endothelial dysfunction.


Dr Piotr Kanclerz

Latest:

Extended depth-of-field IOLs: Clarification of current nomenclature

Clinicians and surgeons should be aware of the misleading use of the EDOF concept. The authors herein propose an alternative terminology and that lenses which have combined optical designs are referred to as ‘hybrid IOLs’.




Mohammad Rafieetary, OD, FAAO

Latest:

Experts say revakinagene taroretcel-lwey approval may represent dawn of new treatments for neurodegenerative conditions

Clinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2



Dr Antonio Fea

Latest:

A new route to reducing IOP

To date, the suprachoroidal space has not been a feasible route to reduce intraocular pressure in glaucoma. A new device promises to change that.



Dr Manuele Michelessi

Latest:

Using pivotal study data to guide glaucoma patient management decisions

Two randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.


By Louise Gagnon; Reviewed by Dr Wai-Ching Lam

Latest:

Surgical management of posterior uveitis in children

Vitrectomy is a tool that can help surgeons curb complications



Leon Herndon Jr, MD

Latest:

Helping patients with glaucoma manage mental health

The link between eye health and mental health may be deeper than previously believed


By Lynda Charters; reviewed by Gavin Li, MS

Latest:

The consequences of dry eye disease: incidence of psychiatric disorders, fibromyalgia and chronic fatigue following diagnosis

Dry eye increases susceptibility to psychiatric disorders and chronic pain syndromes, investigators reported at the 2024 AAO meeting



Dr László Závori

Latest:

Amblyopia screening with the dynamic random dot stereotest

A new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.


Lynda Charters; Reviewed by Dr Jennifer E. Thorne

Latest:

Uveitis: A leading and underestimated cause of visual morbidity in patients

Ophthalmologists are seeking improved treatment options for uveitis as epidemiological studies demonstrate the scope and sight-stealing burden of the disease.


Baruch Kuppermann, MD, PhD

Latest:

Up for debate: Clinicians take on hot topics at the Congress on Controversies in Ophthalmology

This year, the COPHy meeting moves beyond retina, addressing uveitis, neuro-ophthalmology and glaucoma in Seville, Spain


Dr András Czigler

Latest:

Amblyopia screening with the dynamic random dot stereotest

A new amblyopia screening system that can be used on Android devices has performed better than some of the ‘gold standard’ stereotests in recent Hungarian studies.


Dr Dan Z. Reinstein

Latest:

Non-linear aspheric corneal ablation can be used to treat presbyopia

Presbyopia can be treated in emmetropic, myopic and hyperopic patients with refractive errors between +5.75 and -9.00 D using corneal non-linear aspheric ablation profiles to increase the depth of field in both eyes, in combination with micro-monovision. Patient satisfaction with this approach is high.


Dr Sheetal Brar, MS

Latest:

Myth or reality? Corneal refractive surgery to manage presbyopic patients

A corneal refractive technique can combine monovision and extended depth of field to create a wide, seamless range of functional vision. This can provide independence from spectacles.


Caroline Catt, MB, BS, FRANZCO

Latest:

Crafting an international database for retinopathy of prematurity

Intercontinental collaboration is key to unlocking ROP in our lifetime


Shigeru Kinoshita, MD, PhD; and Edward J. Holland, MD

Latest:

Innovation and the clinician scientist

Collaboration and outside-the-box thinking present significant opportunities for science and industry


Bonnie An Henderson, MD

Latest:

AAO 2024: Advancing medical education with AI, robotics, and diverse learning methods

In her Kelman Lecture presentation, Bonnie An Henderson, MD, highlights the importance of continuous education for clinicians.


Lisa Stewart, PhD

Latest:

The pathophysiology and pathomorphology of corneal ectasia: Part 4

Corneal cross-linking (CXL) is improving all the time, although all protocols retain the basic requirements for oxygen, riboflavin and UV light. Recent developments mean that CXL at the slit lamp is feasible, which will improve access to the procedure.


Prof. Boris Malyugin

Latest:

Simplifying cataract surgery in patients with poor mydriasis, compromised zonules

The Malyugin Ring 2.0 simplifies challenging cases of small pupils with zonulopathy by both stabilising the capsular bag and dilating the pupil.

© 2025 MJH Life Sciences

All rights reserved.